Hormonal
Neck circumference (NC) is uniquely associated with the prevalence of common carotid artery (CCA) plaque in diabetic adults, independent of other abdominal obesity indices.
Measuring neck circumference is a simple, low-cost screening tool for diabetic patients to assess the risk of carotid artery plaque. Clinicians should incorporate NC measurements into routine diabetes care to identify patients at higher risk for vascular complications, especially since it provides unique information not captured by waist circumference or BMI.
a one SD increase in NC was significantly associated with a greater prevalence of CCA plaque both in men (OR 1.26; 95% CI 1.10, 1.44) and women (OR 1.20; 95% CI 1.07, 1.35)... NC was unique associated with the prevalence of CCA plaque
Why this rating
Large sample size and adjustment for confounders.
Source
Associations between abdominal obesity indices and diabetic complications: Chinese visceral adiposity index and neck circumference
Heng Wan et al. · Cardiovascular Diabetology · 2020
DOI 10.1186/s12933-020-01095-4
More from this paper
- Higher Chinese visceral adiposity index (CVAI) is significantly associated with increased prevalence of cardiovascular disease (CVD) and diabetic kidney disease (DKD) in diabetic adults, independent of BMI.Good
- Abdominal obesity indices (CVAI, NC, WC, WHR, LAP, VAI) are not associated with the prevalence of diabetic retinopathy (DR) in diabetic adults, regardless of BMI adjustment.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →